The normal hematocrit study--follow-up.
Besarab
Anatole
A
Goodkin
David A
DA
Nissenson
Allen R
AR
D000740:Anemia / Q000188:drug therapy*; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006333:Heart Failure / Q000097:blood* / Q000150:complications / Q000401:mortality; D006400:Hematocrit; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D009203:Myocardial Infarction / Q000453:epidemiology; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins; D006435:Renal Dialysis; D016019:Survival Analysis
D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa